We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$57.2B
AUM Growth
+$551M
Cap. Flow
-$331M
Cap. Flow %
-0.58%
Top 10 Hldgs %
31.76%
Holding
1,006
New
143
Increased
295
Reduced
385
Closed
137

Sector Composition

Rank Sector Weight
1 Technology 29.09%
2 Healthcare 13.87%
3 Financials 11.48%
4 Consumer Discretionary 10.65%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKR icon
501
Baker Hughes
BKR
$62.3B
$15.4M 0.03%
374,502
-96,900
-21% -$3.91M
TEL icon
502
TE Connectivity
TEL
$62.3B
$15.2M 0.03%
106,073
-97,871
-48% -$14.6M
NARI
503
DELISTED
Inari Medical, Inc. Common Stock
NARI
$15.1M 0.03%
+296,543
New +$14.6M
EMN icon
504
Eastman Chemical
EMN
$8.4B
$15.1M 0.03%
165,343
+25,200
+18% +$2.58M
TW icon
505
Tradeweb Markets
TW
$21.8B
$15.1M 0.03%
+115,000
New +$15.2M
FDS icon
506
Factset
FDS
$9.77B
$15M 0.03%
31,300
+17,900
+134% +$8.5M
LXP icon
507
LXP Industrial Trust
LXP
$3.57B
$15M 0.03%
370,000
+140,000
+61% +$6.49M
OKE icon
508
Oneok
OKE
$55.4B
$14.9M 0.03%
148,300
-167,300
-53% -$17.1M
SIRI icon
509
SiriusXM
SIRI
$10.1B
$14.8M 0.03%
650,722
-600,000
-48% -$15.3M
VIAV icon
510
Viavi Solutions
VIAV
$10B
$14.7M 0.03%
1,455,590
-780,612
-35% -$7.71M
BBOT
511
BridgeBio Oncology
BBOT
$703M
$14.7M 0.03%
1,400,000
ELVN icon
512
Enliven Therapeutics
ELVN
$4.31B
$14.6M 0.03%
650,000
-150,000
-19% -$3.89M
KVUE icon
513
Kenvue
KVUE
$36.8B
$14.6M 0.03%
683,258
-2,012,173
-75% -$45.6M
LXEO icon
514
Lexeo Therapeutics
LXEO
$357M
$14.5M 0.03%
2,209,615
-388,121
-15% -$3.06M
WMS icon
515
Advanced Drainage Systems
WMS
$11.4B
$14.4M 0.03%
125,000
+92,000
+279% +$12.8M
BWA icon
516
BorgWarner
BWA
$13.5B
$14.4M 0.03%
454,306
+239,600
+112% +$8.16M
AEVA
517
Aeva Technologies
AEVA
$1.73B
$14.4M 0.03%
3,035,162
-781,590
-20% -$3.16M
AR icon
518
Antero Resources
AR
$10.7B
$14.4M 0.03%
410,696
L icon
519
Loews
L
$23.7B
$14.3M 0.03%
168,900
-2,800
-2% -$231K
INZY
520
DELISTED
Inozyme Pharma
INZY
$14.3M 0.03%
5,160,000
-513,629
-9% -$1.95M
HUM icon
521
Humana
HUM
$44.1B
$14.2M 0.02%
55,962
-35,486
-39% -$9.52M
PTC icon
522
PTC
PTC
$16B
$14.2M 0.02%
77,200
+7,500
+11% +$1.42M
LNT icon
523
Alliant Energy
LNT
$18B
$14.2M 0.02%
+239,708
New +$14.5M
DLTR icon
524
Dollar Tree
DLTR
$24.9B
$14.2M 0.02%
188,838
-1,600
-0.8% -$110K
FULC icon
525
Fulcrum Therapeutics
FULC
$288M
$14.1M 0.02%
3,000,000
+1,000,000
+50% +$3.69M

Similar funds

Adage Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Adage Capital Partners held 1,006 positions worth $57.2B, up 0.97% from $56.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q4 2024 filing shows 143 new, 295 increased, 385 reduced and 137 closed positions. Its largest new stake was Gilead Sciences: 1,714,130 shares worth $158M. The largest sale was Marathon Oil Corporation, an estimated $221M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q4 2024 buy was Gilead Sciences: 1,714,130 shares worth $158M.
  • Adage Capital Partners added most to ConocoPhillips in Q4 2024, an estimated $247M increase.
  • Adage Capital Partners's biggest Q4 2024 reduction was 3M, cutting an estimated $157M.
  • Adage Capital Partners fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $221M.
  • Adage Capital Partners's ten largest holdings make up 32% of its $57.2B portfolio in Q4 2024.
  • Adage Capital Partners opened 143 new positions and closed 137 in Q4 2024.
  • Adage Capital Partners's portfolio value rose 0.97% quarter-over-quarter to $57.2B.

Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.